Dataset from Efficacy and Safety of Tirzepatide Once Weekly in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-CN)

This is a study of tirzepatide in Chinese participants without Type 2 Diabetes who have obesity or overweight.The main purpose is to learn more about how tirzepatide affects body weight.